YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

In vivo and In vitro Anti-lipid Peroxidative Effect of the Extract Complex of Korean Anti-thirst Drugs

한방 소갈약 추출물 및 복합물에 의한 In vivo 및 In vitro 지질과산화 저해효과

  • Published : 2002.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

In Oriental medicine, the prescriptions composed of several herb medicines have been used. It is still unclear how the sum of several extracts of anti-thirst drugs represents the anti-lipid peroxidative action. Three anti-thirst herb medicines, Kalopanax pictus (K), Pueraria thunbergiana (P) and Rhus verniciflua (R), were extracted with MeOH and $H_2O$, respectively, and the former one was fractionated into the resultant EtOAc extract. Each extract was reconstituted to give KPR311, KPR131 and KPR113 where, for example, KPR311 represents the complex of K-P-R {3:1:1 (w/w/w)} of the three extracts. The order of the inhibitory effect in bromobenzene-induced lipid peroxidation in rats was as follows: EtOAc extract＞$H_2O$ extract＞MeOH extract. Extract complexes were found to be more potent than the extracts of individual crude drugs. The KPR131 of EtOAc extract was found to be the most potent among the tested samples. These anti-lipid peroxidative effects were also supported by the decrease of aniline hydroxylase activity and aminopyrine N-demethylase activity, on the other hand by the increase of epoxide hydrolase activity. All the tested samples were assayed in vitro antioxidative effects such as DPPH assay, ADP/NADPH/Fe$^{3+}$ assay and ascorbic acid/Fe$^{2+}$ assay. The EtOAc extracts also showed the most significant antioxidative effects. These results suggest that the sum of anti-thirst drugs could reflect the effects of respective crude drugs.s.s.

Keywords

References

  1. 지형준, 이상인: 대한약전외 한약(생약) 규격집 주해서, 한국메디컬인덱스스사, 서울 (1998)
  2. Lee, K. T., Shon, I. C., Park, H. J., Kim, D. W., Jung, G. O. and Park, K. Y.: Essential Moiety for Antimutagenic and Cytotoxic Activity of Hederagenin Monodesmosides Isolated from the Stem Bark of Kalopanax pictus. Planta Med. 66, 329 (2000) https://doi.org/10.1055/s-2000-8539
  3. Park, K. Y., Jung, G. O., Choi, J. W., Lee, K. T. and Park, H. J. : Potent Antimutagenic and Their Anti-Lipid Peroxidative Effect of Kaikasaponin III and Tectorigenin from the Flower of Pueraria thunbergiana. Arch. Pharm. Res. 25(3), 320 (2002)
  4. Park, H. J., Kwon, S. H., Kim, G.T., Lee, K. T., Jung, G. O. and Choi, J. W. :The pharmaceutical society of Korea, Anticarcinogenic effect of the heartwood of Rhus verniciflua and its active principles. The Spring Convention of the Pharmaceutical Society of Korea 188 (2000)
  5. Kim, D. H., Kim, E. A., Han, M. J., Park, H. J., and Choi, J. W. : Metabolism of kalopanaxsaponin K by human intestinal bacteria and antitrheumatoidal arthritis activity of their metabolites. Biol. Pharm. Bull. 25(1), 68 (2002)
  6. Kim, D. H., Lee, K. T., Bae, E. A., Han, M. J. and Park, H. J. : Metabolism of Liriodendrin and Syringin by Human Intestinal Bacteria and their relation to in vitro Cytotoxicity. Arch. Pharm. Res. 22(1), 30 (1999)
  7. Lee, K. T., Sohn, I. C., Kim, Y. K., Choi, J. H., Choi, J. W., Park, H. J., Itoh, Y. and Miyamoto, K. I. : Tectorigenin, an Isoflavone of Pueraria thunbergiana Benth, Induces Differentiation and Apoptosis in Human Promyelocytic Leukemia HL-60 Cells. Biol. Pharm. Bull. 24(10), 1117 (2001)
  8. Kiong, Q. B., Tezuka, T., Kaneko T., Li, H., Tran, L. Q., Hase, K., Namba, T. and Kadota, S.: Inhibition of nitric oxide by ohenylpropanoids in activated macrophage. Eur. J. Pharmacol. 400, 137 (2000) https://doi.org/10.1016/S0014-2999(00)00354-X
  9. Ohkawa, H., Ohishi, N., and Yagi, K. : Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal. Biochem. 95, 351 (1979) https://doi.org/10.1016/0003-2697(79)90738-3
  10. Nash, T. : The colorimetric estimation of formaldehyde by means of the hantzsch reaction. J. Biol. Chem. 55, 416 (1953)
  11. Bidlack, W. R., and Lowery, G. L. : Multiple drug metabolism: P-nitroanisole reversal ofacetone enhanced aniline hydroxylation. Biochem. Pharmacol. 31, 311 (1982)
  12. Habig, W. H., Pabist, M. J. and Jakoby, W. B. : Glutathione S-Transferases : The first enzymatic step in mercapturic acid formation, J. Biol. Chem. 249, 7130 (1974)
  13. Kiso, Y., Tohkin, M., Hikio, H., Hattori, M., Sakamoto, T. and Namba, Y. : Mechanism of antihepatotoxic activityof glycyrrhizin. Planta Med. 50, 298 (1984) https://doi.org/10.1055/s-2007-969714
  14. Schaffner, F. : Hepatic drug metabolism and adverse hepatic drug reactions. Vet. Pathol. 12, 145 (1975)
  15. Singh, A. and Rao, A. R.: Effects of arecoline on phase I and phase II drug metabolizing system enzymes, sulfhydryl content and lipid peroxidation in mouse liver, Biochem. Mol. Biol. Int. 30, 763 (1993)
  16. Morgan, E. T. : Regulation of cytochrome P450 durig inflammation and infection. Drug Metab. Rev. 29, 1129 (1997) https://doi.org/10.3109/03602539709002246
  17. Halliwell, B. : Biochemical mechanism accounting for the toxic action of oxygen on living organism. Cell Biol. Int. Rep. 2, 112 (1978)
  18. Deneke, S. M. and Fanburg, B. L. : Normobaric oxygen toxicity of the lung. New Engl. J. Med. 303, 76 (1980)
  19. Lee, K. T., Sohn, I. C., Kim, D. H., Choi, J. W., Kwon, S. H. and Park, H. J. : Hypoglycemic and hypolipidemic effects of tectorigenin and kaikasaponin III in the streptozotocin-induced diabetic rat and their antioxidant activity in vitro. Arch. Pharm. Res. 23(5), 461 (2000)
  20. Choi, J. W., Han, Y. N., Lee, K. T., Park, K. Y., Kwak, T. S., Kwon, S. H., and Park, H. J. : Anti-lipid peroxidative principles from the stem bark of Kalopanax pictus Nakai, Arch. Pharm. Res. 24, 536 (2001) https://doi.org/10.1007/BF02975161